This cannabis psychosis risk review examines how the 2026 JAMA Internal Medicine paper interprets observational mental health data. The analysis explores confounding, reverse causation, exposure definition problems, and the difference between relative and absolute risk. It also explains what cautious clinicians can responsibly conclude about cannabis, psychosis risk, bipolar disorder, anxiety, and adolescent exposure.
Endocannabinoid System Psychosis Risk: Clinical Research Guide
Clinical Takeaway Clinical Takeaway Patients presenting with cannabis-induced psychosis have measurable risk for developing schizophrenia spectrum or bipolar disorder, though distinguishing these primary psychiatric conditions from acute cannabis effects remains clinically challenging....
Cannabidiol Modulates Glutamate Learning Response
Clinical Takeaway A single dose of CBD in people at clinical high risk for psychosis reduced the abnormal connection between high hippocampal glutamate levels and irregular brain activity during memory tasks. This...
Endocannabinoid System Clinical Research on Psychosis Risk
Clinical Takeaway Patients who experience cannabis-induced psychosis have a documented risk of subsequently developing schizophrenia spectrum or bipolar disorder, with prevalence varying across studies due to differences in follow-up duration and diagnostic...
What are the dangers of high-potency cannabis? | Colorado Public Radio
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Thc PotencyCannabis SafetyDosingPsychosis RiskCannabis Use Disorder Why This MattersHigh-potency cannabis products (>20% THC) are...
`Adolescent Cannabis Use & Mental Health Risk: Clinical Evidence`
Clinical Takeaway Cannabis use during adolescence is associated with increased risk of psychotic, bipolar, depressive, and anxiety disorders in large population-based longitudinal data. These findings reflect clinically diagnosed conditions, not just symptoms,...
Endocannabinoid System Research: Teen Cannabis & Mental Health
Clinical Takeaway Adolescent cannabis use is associated with significantly increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large-scale longitudinal population data. These findings...
High-Potency Cannabis Linked to Dramatically Higher Risk of Psychotic Episodes
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthPsychosisHigh-Potency ThcRisk AssessmentPatient Safety Why This MattersThe relationship between high-potency cannabis and psychosis...
Cannabis and Mental Health: Why ‘Cannabis’ and ‘d9-THC’ Are Not the Same Thing
When headlines report that ‘cannabis’ is detrimental for any number of things, the term is almost exclusively used as a proxy for d9-THC.
Cannabis and Mental Health: Why ‘It’s Complicated’ Is Actually the Most Accurate Answer
It is likely more appropriate to view cannabis use as a contributing factor to a condition with a multifactorial etiology (e.g., genetic predisposition, use of other drugs, familial and social factors), or the result of individuals having a shared vulnerability to psychosis and cannabis use.